NCT05693714 is a clinical trial of Pcr in Observational, sponsored by Assiut University.

Who is sponsoring NCT05693714?

NCT05693714 is sponsored by Assiut University.

What drugs are being tested in NCT05693714?

Interventions in NCT05693714: Pcr.

What condition does NCT05693714 study?

NCT05693714 studies Observational.

Is NCT05693714 still recruiting?

NCT05693714 is currently status unknown. Last updated 23 January 2023.

Last reviewed 2023-01-23 · How we verify

NCT05693714

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adenovirus Infection in Children With Autoimmune Hepatitis

Status unknown Last updated 23 January 2023

What this trial tests

trial testing Pcr in Observational in 76 participants. Status unknown.

Timeline

20 January 2023

Primary endpoint
31 December 2024

31 December 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	76
Start date	20 January 2023
Primary completion	31 December 2024
Estimated completion	31 December 2025

Drugs / interventions tested

Conditions studied

Observational — all drugs for Observational →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Observational. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adenoviruses have been linked to severe hepatitis in children. They are non-enveloped, icosahedral viruses of medium size (90-100 nm) (5). Adenoviruses usually infect the respiratory tract, eyes, urinary tract, intestines, and central nervous system (6). These diseases are

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Observational

Currently open trials in the same condition.

NCT03253536 — Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients Wi · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05693714 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 23 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05693714.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing